Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Postoperative Hemorrhage × Clear all

Phase

Phase NA 2 Phase 4 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2403 Carcinoma, Non-Small-Cell Lung 1951 Prostatic Neoplasms 1261 Colorectal Neoplasms 1123 Neoplasms 1071 Multiple Myeloma 928 Lung Neoplasms 908 Neoplasm Metastasis 877 Leukemia, Myeloid, Acute 845 Lymphoma 778 Melanoma 760 Pancreatic Neoplasms 717 Ovarian Neoplasms 694 Carcinoma, Hepatocellular 670 Stomach Neoplasms 657 Recurrence 657 Leukemia 645 Lymphoma, Non-Hodgkin 594 Leukemia, Lymphocytic, Chronic, B-Cell 571 Squamous Cell Carcinoma of Head and Neck 538 Lymphoma, Large B-Cell, Diffuse 537 Brain Neoplasms 524 Head and Neck Neoplasms 521 Precursor Cell Lymphoblastic Leukemia-Lymphoma 520 Glioblastoma 508 Carcinoma, Renal Cell 504 Rectal Neoplasms 492 Myelodysplastic Syndromes 453 Sarcoma 451 Lymphoma, Follicular 443

Interventions

Tranexamic Acid 1 Therapeutics 1 Standard of Care 1 Lidocaine 1 Epinephrine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06057675 2025-08-19

Tranexamic Acid in Nasal Mohs Reconstruction

Vanderbilt University Medical Center

Phase 2 Recruiting

Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡